PRO-XTEN Trademark

Trademark Overview

On Monday, October 4, 2021, a trademark application was filed for PRO-XTEN with the United States Patent and Trademark Office. The USPTO has given the PRO-XTEN trademark a serial number of 97059027. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, February 28, 2026. This trademark is owned by Amunix Pharmaceuticals, Inc.. The PRO-XTEN trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Chemicals used in the manufacture of pharmaceuticals; biomedical compounds, namely, recombinant and synthetic polypeptides for universal masking of proteins and providing half-life extension, and protease-cleavable linkers to enable unmasking

Pharmaceutical preparations for the treatment of cancerous and viral diseases; pharmaceutical preparations for use in the field of oncology for the treatment of cancerous diseases; medical diagnostic reagents
pro-xten

General Information

Serial Number97059027
Word MarkPRO-XTEN
Filing DateMonday, October 4, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, February 28, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements

Goods and ServicesChemicals used in the manufacture of pharmaceuticals; biomedical compounds, namely, recombinant and synthetic polypeptides for universal masking of proteins and providing half-life extension, and protease-cleavable linkers to enable unmasking
Goods and ServicesPharmaceutical preparations for the treatment of cancerous and viral diseases; pharmaceutical preparations for use in the field of oncology for the treatment of cancerous diseases; medical diagnostic reagents

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, June 10, 2022
Primary Code001
First Use Anywhere DateSaturday, December 31, 2022
First Use In Commerce DateSaturday, December 31, 2022
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 10, 2022
Primary Code005
First Use Anywhere DateSaturday, December 31, 2022
First Use In Commerce DateSaturday, December 31, 2022

Trademark Owner History

Party NameAmunix Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
US
Party NameAmunix Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
US

Trademark Events

Event DateEvent Description
Thursday, October 7, 2021NEW APPLICATION ENTERED
Friday, October 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 2, 2022ASSIGNED TO EXAMINER
Friday, June 10, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, June 10, 2022EXAMINERS AMENDMENT E-MAILED
Friday, June 10, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 10, 2022EXAMINER'S AMENDMENT ENTERED
Friday, June 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 6, 2023SOU EXTENSION 1 FILED
Monday, March 6, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 13, 2023SOU EXTENSION 2 FILED
Wednesday, September 13, 2023SOU EXTENSION 2 GRANTED
Friday, September 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 13, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, April 3, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 13, 2024SOU EXTENSION 3 FILED
Wednesday, April 3, 2024SOU EXTENSION 3 GRANTED
Wednesday, March 13, 2024USE AMENDMENT FILED
Wednesday, April 3, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 4, 2024SU - NON-FINAL ACTION - WRITTEN
Saturday, May 4, 2024NON-FINAL ACTION E-MAILED
Saturday, May 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 2, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, August 2, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, September 13, 2024SOU TEAS EXTENSION RECEIVED
Monday, November 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 10, 2024ASSIGNED TO LIE
Tuesday, December 10, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 7, 2025SU - FINAL REFUSAL - WRITTEN
Friday, February 7, 2025FINAL REFUSAL E-MAILED
Friday, February 7, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, May 7, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, May 7, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, August 7, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, August 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 8, 2025ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Friday, August 8, 2025ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Friday, August 8, 2025NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Saturday, February 28, 2026ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, February 28, 2026ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Related Keywords

xten treatment diseases preparations cancerous pharmaceutical unmasking cleavable linkers enable viral